Three holdings in our utility coverage universe recently cut dividends; what makes them unique is that I still rate all of them as buys, as their decisions to hold in cash now...
Stocks & Options
Harry Boxer list the best breakout opportunities based on price and volume from earlier this week....
ePlus Inc. (PLUS) is an information technology (IT) solutions provider operating from 35 locations serving U.S., Europe, and Asia-Pacific markets, observes Douglas Gerlach, ed...
Alan Ellman explains how to turn a losing trade into a winner through rolling covered calls....
Trading
Stimulus Stall
Phil Flynn breaks down the potential for another round of stimulus and its impact on energy markets....
Trading
Whirlpool Shouting Sell
Daniel Collins points out an extreme overbought stock, which just posted a bearish QuantCycles turn....
Investing
Three Apparel Makers in the Bargain Bin
Like many consumer goods producers, companies that make apparel have experienced sharply lower sales and profits with the pandemic restrictions, obser...
Investing
Five Reasons to Buy Costco
I seldom make it out of Costco (COST) without dropping $400, or more. That’s because the deals are just too good to pass up. If you’re a C...
Investing
Bristol-Myers Squibb: A Pipeline to Profits
Tickers:
BMY
The most important question you can ask about the typical big drugmaker is whether its pipeline will support outsized growth in the future; at Bristol...
Trading
Trading
Chipmaker Likely to Outperform Sector
Tickers:
XLNX
Joe Duarte shares the one stock in the semiconductor space like to outperform....
Trading
The Coming Saudi Oil Shock and the World Economy
Phil Flynn discusses the coming Saudi oil shock and the world economy....
Investing
COVID Causes an Outbreak in Cybercrime: These Security Stocks Can Help
The Covid-19 outbreak has resulted in a surge of targeted cyberattacks. From a cybercrime perspective, Covid-19 revealed a new breed of bad actors, so...
Investing
GW Pharmaceuticals: Biotech Meets Cannabis
Tickers:
GWPH
GW Pharmaceuticals (GWPH) is one of a growing number of biotechs that after years of R&D have moved firmly into the commercial stage and, in this ...